MDT Stock Summary and Trading Ideas (Medtronic Plc. | NYSE:MDT)

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

Medtronic Plc. trades on the NYSE stock market under the symbol MDT.

As of December 19, 2025, MDT stock price climbed to $98.95 with 1,722,774 million shares trading.

MDT has a beta of 0.63, meaning it tends to be less sensitive to market movements. MDT has a correlation of 0.27 to the broad based SPY ETF.

MDT has a market cap of $126.88 billion. This is considered a Large Cap stock.

Last quarter Medtronic Plc. reported $9 billion in Revenue and $1.36 earnings per share. This beat revenue expectation by $99 million and exceeded earnings estimates by $.05.

In the last 3 years, MDT traded as high as $106.33 and as low as $68.84.

The top ETF exchange traded funds that MDT belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.

MDT has outperformed the market in the last year with a return of +27.2%, while the SPY ETF gained +17.2%. In the last 3 month period, MDT beat the market returning +4.3%, while SPY returned +3.2%. However, in the most recent 2 weeks MDT has underperformed the stock market by returning -3.0%, while SPY returned -0.7%.

MDT support price is $97.32 and resistance is $99.64 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MDT shares will trade within this expected range on the day.